{"title":"地塞米松与COVID-19的关系","authors":"Bianca Mammarella, Sarah Damiani","doi":"10.15173/sciential.v1i9.3198","DOIUrl":null,"url":null,"abstract":"Dexamethasone is known for its use as an anti-inflammatory and immunosuppressant medication. This medication has been present for many years, and its benefits have been observed in the treatment of various conditions. With the rise of COVID-19 cases on an international scale, healthcare professionals globally searched for a therapeutic medication, either existing or under development that could help those who were ill with the virus. The Recovery Trial aims to find a pharmacotherapeutic medication that would assist in treating hospitalized individuals who were diagnosed with COVID-19. In this trial, Dexamethasone’s ability to reduce hospitalization durations, and patient fatality was observed. These results increased curiosity about Dexamethasone's potential in the fight against COVID-19. As we work towards a standardized treatment plan for COVID-19, investigate Dexame- thasone’s mechanisms of action, and how it impacts different populations; together, these findings may help to determine this medication’s effectiveness as a COVID-19 treatment option.","PeriodicalId":262888,"journal":{"name":"Sciential - McMaster Undergraduate Science Journal","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dexamethasone's Connection to COVID-19\",\"authors\":\"Bianca Mammarella, Sarah Damiani\",\"doi\":\"10.15173/sciential.v1i9.3198\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dexamethasone is known for its use as an anti-inflammatory and immunosuppressant medication. This medication has been present for many years, and its benefits have been observed in the treatment of various conditions. With the rise of COVID-19 cases on an international scale, healthcare professionals globally searched for a therapeutic medication, either existing or under development that could help those who were ill with the virus. The Recovery Trial aims to find a pharmacotherapeutic medication that would assist in treating hospitalized individuals who were diagnosed with COVID-19. In this trial, Dexamethasone’s ability to reduce hospitalization durations, and patient fatality was observed. These results increased curiosity about Dexamethasone's potential in the fight against COVID-19. As we work towards a standardized treatment plan for COVID-19, investigate Dexame- thasone’s mechanisms of action, and how it impacts different populations; together, these findings may help to determine this medication’s effectiveness as a COVID-19 treatment option.\",\"PeriodicalId\":262888,\"journal\":{\"name\":\"Sciential - McMaster Undergraduate Science Journal\",\"volume\":\"26 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sciential - McMaster Undergraduate Science Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15173/sciential.v1i9.3198\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sciential - McMaster Undergraduate Science Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15173/sciential.v1i9.3198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Dexamethasone is known for its use as an anti-inflammatory and immunosuppressant medication. This medication has been present for many years, and its benefits have been observed in the treatment of various conditions. With the rise of COVID-19 cases on an international scale, healthcare professionals globally searched for a therapeutic medication, either existing or under development that could help those who were ill with the virus. The Recovery Trial aims to find a pharmacotherapeutic medication that would assist in treating hospitalized individuals who were diagnosed with COVID-19. In this trial, Dexamethasone’s ability to reduce hospitalization durations, and patient fatality was observed. These results increased curiosity about Dexamethasone's potential in the fight against COVID-19. As we work towards a standardized treatment plan for COVID-19, investigate Dexame- thasone’s mechanisms of action, and how it impacts different populations; together, these findings may help to determine this medication’s effectiveness as a COVID-19 treatment option.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
